Loaded from persisted store.
Threads
All Filings
SEC Comment Letters
Company Responses
Letter Text
BEST SPAC I Acquisition Corp.
Response Received
3 company response(s)
High - file number match
↓
Company responded
2025-05-23
BEST SPAC I Acquisition Corp.
References: April 10,
2025
↓
↓
BEST SPAC I Acquisition Corp.
Response Received
1 company response(s)
Medium - date proximity
SEC wrote to company
2025-02-06
BEST SPAC I Acquisition Corp.
Summary
Generating summary...
↓
Company responded
2025-03-28
BEST SPAC I Acquisition Corp.
References: February 6,
2025
Summary
Generating summary...
Summary
| Date | Type | Company | Location | File No | Link |
|---|---|---|---|---|---|
| 2025-06-10 | Company Response | BEST SPAC I Acquisition Corp. | N/A | N/A | Read Filing View |
| 2025-06-10 | Company Response | BEST SPAC I Acquisition Corp. | N/A | N/A | Read Filing View |
| 2025-05-23 | Company Response | BEST SPAC I Acquisition Corp. | N/A | N/A | Read Filing View |
| 2025-04-10 | SEC Comment Letter | BEST SPAC I Acquisition Corp. | N/A | 377-07669 | Read Filing View |
| 2025-03-28 | Company Response | BEST SPAC I Acquisition Corp. | N/A | N/A | Read Filing View |
| 2025-02-06 | SEC Comment Letter | BEST SPAC I Acquisition Corp. | N/A | 377-07669 | Read Filing View |
| Date | Type | Company | Location | File No | Link |
|---|---|---|---|---|---|
| 2025-04-10 | SEC Comment Letter | BEST SPAC I Acquisition Corp. | N/A | 377-07669 | Read Filing View |
| 2025-02-06 | SEC Comment Letter | BEST SPAC I Acquisition Corp. | N/A | 377-07669 | Read Filing View |
| Date | Type | Company | Location | File No | Link |
|---|---|---|---|---|---|
| 2025-06-10 | Company Response | BEST SPAC I Acquisition Corp. | N/A | N/A | Read Filing View |
| 2025-06-10 | Company Response | BEST SPAC I Acquisition Corp. | N/A | N/A | Read Filing View |
| 2025-05-23 | Company Response | BEST SPAC I Acquisition Corp. | N/A | N/A | Read Filing View |
| 2025-03-28 | Company Response | BEST SPAC I Acquisition Corp. | N/A | N/A | Read Filing View |
2025-06-10 - CORRESP - BEST SPAC I Acquisition Corp.
CORRESP 1 filename1.htm BEST SPAC I Acquisition Corp. 701, 7/Floor United Building 17-19 Jubilee Street Hong Kong June 10, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 RE: BEST SPAC I Acquisition Corp. (the "Company") Registration Statement on Form S-1 (File No. 333-286237) (the "Registration Statement") Ladies and Gentlemen: The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:30 p.m., Eastern time, on June 12, 2025, or as soon thereafter as practicable. The Company hereby acknowledges that: ● Should the Securities and Exchange Commission (the "Commission") or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement; ● The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and ● The Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. If there is any change in the acceleration request set forth above, the Company will promptly notify you of the change, in which case the Company may be making an oral request of acceleration of the effectiveness of the Registration Statements in accordance with Rule 461 of Regulation C. Such request may be made by an executive officer of the Company or by any attorney from the Company's U.S. counsel, Loeb & Loeb LLP. [ Signature page follows ] Very truly yours, BEST SPAC I Acquisition Corp. By: /s/ Xiangge Liu Name: Xiangge Liu Title: Chief Executive Officer
2025-06-10 - CORRESP - BEST SPAC I Acquisition Corp.
CORRESP 1 filename1.htm June 10, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Attn: Isabel Rivera Re: BEST SPAC I Acquisition Corp. Registration Statement on Form S-1, as amended (File No. 333-286237) Request for Acceleration of Effectiveness Ladies and Gentlemen: As the representative of the underwriters of the proposed initial public offering of BEST SPAC I Acquisition Corp. (the "Company"), we hereby join the Company's request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:30 pm Eastern Time, on June 12, 2025, or as soon thereafter as is practicable. Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through June 12, 2025, we distributed to each dealer, institutional investor, or retail investor, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as "E-red" copies of the Preliminary Prospectus dated May 23, 2025, as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours Maxim Group LLC By: /s/ Larry Glassberg Name: Larry Glassberg Title: Co-Head of Investment Banking, Executive Managing Director
2025-05-23 - CORRESP - BEST SPAC I Acquisition Corp.
CORRESP 1 filename1.htm Giovanni Caruso Partner 345 Park Avenue Direct 212.407.4866 New York, NY 10154 Main 212.407.4000 Fax 212.937.3943 gcaruso@loeb.com May 23, 2025 Ameen Hamady Kristina Marrone Isabel Rivera Benjamin Holt Division of Corporation Finance U.S. Securities & Exchange Commission Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549 Re: BEST SPAC I Acquisition Corp. Registration Statement on Form S-1 Filed March 28, 2025 File No. 333-286237 Ladies and Gentlemen: On behalf of our client, BEST SPAC I Acquisition Corp. (the "Company"), we hereby provide a response to the comments issued in a letter dated April 10, 2025 (the "Staff's Letter") regarding the above-referenced Registration Statement on Form S-1 (the "Registration Statement"). Contemporaneously, the Company is filing a revised Registration Statement via EDGAR (the "Amended Registration Statement"), which reflects the Company's responses to the comments received by the Staff and certain updated information. In order to facilitate the review by the staff of the Securities and Exchange Commission (the "Staff") of the Amended Registration Statement, we have responded, on behalf of the Company, to the comment set forth in the Staff's Letter. The numbered paragraphs set forth below respond to the Staff's comments and correspond to the numbered paragraph in the Staff's Letter. Registration Statement on Form S-1 filed March 28, 2025 Note 2 - Basis of Presentation and Summary of Significant Accounting Policies Recent Accounting Pronouncements, page F-12 1. We note your disclosure that Company's management does not believe that the adoption of ASU 2023-07 will have a material impact on the audited financial statements and disclosures. Please tell us how the Company considered the additional reportable segment disclosure requirements of ASU 2023-07. Please advise or revise accordingly. Response: In response to the Staff's comment, the Company has revised the disclosure on pages F-33-34 of the Amended Registration Statement. U.S. Securities and Exchange Commission May 23, 2025 Page 2 Please call me at (212) 407-4866 if you would like additional information with respect to any of the foregoing. Thank you. /s/ Giovanni Caruso Giovanni Caruso Partner
2025-04-10 - UPLOAD - BEST SPAC I Acquisition Corp. File: 377-07669
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 10, 2025 Xiangge Liu Chairman, Chief Executive Officer and Chief Financial Officer BEST SPAC I Acquistion Corp. 701, 7/Floor United Building 17-19 Jubilee Street Hong Kong Re: BEST SPAC I Acquistion Corp. Registration Statement on Form S-1 Filed March 28, 2025 File No. 333-286237 Dear Xiangge Liu: We have reviewed your registration statement and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Registration Statement on Form S-1 filed March 28, 2025 Note 2 - Basis of Presentation and Summary of Significant Accounting Policies Recent Accounting Pronouncements, page F-12 1. We note your disclosure that Company's management does not believe that the adoption of ASU 2023-07 will have a material impact on the audited financial statements and disclosures. Please tell us how the Company considered the additional reportable segment disclosure requirements of ASU 2023-07. Please advise or revise accordingly. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. April 10, 2025 Page 2 Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Ameen Hamady at 202-551-3891 or Kristina Marrone at 202-551-3429 if you have questions regarding comments on the financial statements and related matters. Please contact Isabel Rivera at 202-551-3518 or Benjamin Holt at 202-551-6614 with any other questions. Sincerely, Division of Corporation Finance Office of Real Estate & Construction cc: Giovanni Caruso </TEXT> </DOCUMENT>
2025-03-28 - CORRESP - BEST SPAC I Acquisition Corp.
CORRESP 1 filename1.htm Giovanni Caruso Partner 345 Park Avenue Direct 212.407.4866 New York, NY 10154 Main 212.407.4000 Fax 212.937.3943 gcaruso@loeb.com March 28, 2025 Ameen Hamady Kristina Marrone Isabel Rivera Benjamin Holt Division of Corporation Finance U.S. Securities & Exchange Commission Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549 Re: BEST SPAC I Acquisition Corp. Draft Registration Statement on Form S-1 Submitted January 10, 2025 CIK No. 0002051587 Ladies and Gentlemen: On behalf of our client, BEST SPAC I Acquisition Corp. (the "Company"), we hereby provide a response to the comments issued in a letter dated February 6, 2025 (the "Staff's Letter") regarding the above-referenced Draft Registration Statement on Form S-1 (the "Registration Statement"). Contemporaneously, the Company is filing a revised Registration Statement via EDGAR (the "Amended Registration Statement"), which reflects the Company's responses to the comments received by the Staff and certain updated information. In order to facilitate the review by the staff of the Securities and Exchange Commission'"" of the Amended Registration Statement, we have responded, on behalf of the Company, to the comment set forth in the Staff's Letter. The numbered paragraphs set forth below respond to the Staff's comments and correspond to the numbered paragraph in the Staff's Letter. Draft Registration Statement on Form S-1 submitted January 10, 2025 Cover Page 1. We note that you checked the Rule 415 box on the cover page, but your disclosure elsewhere indicates that this is a firm commitment, underwritten offering. Please advise or revise accordingly. Response: In response to the Staff's comment, the Company has revised the disclosure on the cover page of the Amended Registration Statement. Los Angeles New York Chicago Nashville Washington, DC San Francisco Beijing Hong Kong www.loeb.com For the United States offices, a limited liability partnership including professional corporations. For Hong Kong office, a limited liability partnership. U.S. Securities and Exchange Commission March 28, 2025 Page 2 2. We note your disclosure regarding compensation and securities issuance. Please expand your disclosure to state whether the conversion of the working capital loans into private placement units may result in a material dilution of the purchasers' equity interests. Refer to Item 1602(a)(3) of Regulation S-K. Response: In response to the Staff's comment, the Company has revised the disclosure on the cover page and pages 3, 6 and 133 of the Amended Registration Statement. 3. Please reconcile your statement here and on page 15 of your prospectus that your officers and directors will maintain their fiduciary duty and that you will retain priority over any subsequent SPACs or ventures they may join with your disclosure on page 18 and elsewhere throughout your prospectus that you have renounced your interest or expectancy in any corporate opportunity offered to an officer or director which is suitable to another entity to which they owe fiduciary or contractual obligations unless the opportunity is presented to such officer and director in their capacity as an officer or director of your company. Response: In response to the Staff's comment, the Company has revised the disclosure on the cover page and pages 11, 17, 135 and 158-159 of the Amended Registration Statement. Prospectus Summary Leadership of an Experienced Management and Director Team, page 4 4. Please revise your disclosure here, under "Other Acquisition Considerations" on page 14, under "Potential Conflicts" on page 18, and elsewhere as appropriate to reference all positions currently held by your management team. Also revise to reconcile your statement on pages 15, 18, and 130, "None of our other officers or directors has any previous or current experience with a special purpose acquisition company." In this regard, we note that your management team simultaneously maintains positions with BEST SPAC II Acquisition Corp. Response: In response to the Staff's comment, the Company has revised the disclosure on pages 4-5, 11, 16, 20, 57, 127-128, 132, 161-162, 167 and 169-170 of the Amended Registration Statement. Compensation, page 5 5. Please revise your disclosure outside the table on pages 5-6 to describe the extent to which this compensation and securities issuance may result in a material dilution of the purchasers' equity interests, including the conversion of the working capital loans into private placement units. Refer to Item 1602(b)(6) of Regulation S-K. Response: In response to the Staff's comment, the Company has revised the disclosure on the cover page and pages 3, 6 and 133 of the Amended Registration Statement. Legal and Operational Risks Associated with being based in China, page 10 6. Please expand to disclose the basis for your belief that for this offering you are not subject to registration with the CSRC pursuant to the Trial Measures, as you state on page 89. Response: In response to the Staff's comment, the Company has revised the disclosure on page 13 of the Amended Registration Statement. U.S. Securities and Exchange Commission March 28, 2025 Page 3 Private placement units, page 28 7. We note your statement here and elsewhere throughout your prospectus that your private placement units are identical to the units sold in this offering "except as described in this prospectus." Other than the transfer restrictions on the private placement units, please describe or provide a cross-reference to disclosure elsewhere that describes, how the private placement units, including the component securities, are not identical to the units sold in this offering. Response: In response to the Staff's comment, the Company has revised the disclosure on the cover page and pages 30, 76, 125, 133, 173, 175 and 182 of the Amended Registration Statement. Risk Factors Risks Relating to our Sponsor, Management and Director Team The ownership interest of our sponsor may change, and our sponsor may divest its ownership interest in us before identifying . . ., page 68 8. Please revise your risk factor disclosure to state the risk, if applicable, that any replacement sponsor could have difficulty finding a target. Response: In response to the Staff's comment, the Company has revised the disclosure on pages 70-71 of the Amended Registration Statement. Risks Associated with Acquiring and Operating a Business with its Primary Operation in China Other PRC governmental authorities may take the view now or in the future that an approval from them is required for an overseas . . ., page 87 9. Please revise your risk factor disclosure to specifically address the impact that PRC law or regulation may have on the cash flows associated with the business combination, including shareholder redemption rights. Response: In response to the Staff's comment, the Company has revised the disclosure on page 92 of the Amended Registration Statement. General 10. Please disclose the material terms of any agreement regarding transfer restrictions on your securities in a tabular format to the extent practicable, as required by Item 1603(a)(9) of Regulation S-K. Response: In response to the Staff's comment, the Company has revised the disclosure on pages 7-8 and 135-137 of the Amended Registration Statement. Please call me at (212) 407-4866 if you would like additional information with respect to any of the foregoing. Thank you. /s/ Giovanni Caruso Giovanni Caruso Partner
2025-02-06 - UPLOAD - BEST SPAC I Acquisition Corp. File: 377-07669
February 6, 2025
Xiangge Liu
Chairman, Chief Executive Officer and Chief Financial Officer
BEST SPAC I Acquistion Corp.
701, 7/Floor
United Building
17-19 Jubilee Street
Hong Kong
Re:BEST SPAC I Acquistion Corp.
Draft Registration Statement on Form S-1
Submitted January 10, 2025
CIK No. 0002051587
Dear Xiangge Liu:
We have reviewed your draft registration statement and have the following comments.
Please respond to this letter by providing the requested information and either
submitting an amended draft registration statement or publicly filing your registration
statement on EDGAR. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing the information you provide in response to this letter and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Draft Registration Statement on Form S-1 submitted January 10, 2025
Cover Page
1.We note that you checked the Rule 415 box on the cover page, but your disclosure
elsewhere indicates that this is a firm commitment, underwritten offering. Please
advise or revise accordingly.
2.We note your disclosure regarding compensation and securities issuance. Please
expand your disclosure to state whether the conversion of the working capital loans
into private placement units may result in a material dilution of the purchasers' equity
interests. Refer to Item 1602(a)(3) of Regulation S-K.
February 6, 2025
Page 2
3.Please reconcile your statement here and on page 15 of your prospectus that your
officers and directors will maintain their fiduciary duty and that you will retain
priority over any subsequent SPACs or ventures they may join with your disclosure
on page 18 and elsewhere throughout your prospectus that you have renounced your
interest or expectancy in any corporate opportunity offered to an officer or director
which is suitable to another entity to which they owe fiduciary or contractual
obligations unless the opportunity is presented to such officer and director in their
capacity as an officer or director of your company.
Prospectus Summary
Leadership of an Experienced Management and Director Team, page 4
4.Please revise your disclosure here, under "Other Acquisition Considerations" on page
14, under "Potential Conflicts" on page 18, and elsewhere as appropriate to
reference all positions currently held by your management team. Also revise to
reconcile your statement on pages 15, 18, and 130, "None of our other officers or
directors has any previous or current experience with a special purpose acquisition
company." In this regard, we note that your management team simultaneously
maintains positions with BEST SPAC II Acquisition Corp.
Compensation, page 5
5.Please revise your disclosure outside the table on pages 5-6 to describe the extent to
which this compensation and securities issuance may result in a material dilution of
the purchasers' equity interests, including the conversion of the working capital loans
into private placement units. Refer to Item 1602(b)(6) of Regulation S-K.
Legal and Operational Risks Associated with being based in China, page 10
6.Please expand to disclose the basis for your belief that for this offering you are not
subject to registration with the CSRC pursuant to the Trial Measures, as you state on
page 89.
Private placement units, page 28
7.We note your statement here and elsewhere throughout your prospectus that your
private placement units are identical to the units sold in this offering "except as
described in this prospectus." Other than the transfer restrictions on the private
placement units, please describe or provide a cross-reference to disclosure elsewhere
that describes, how the private placement units, including the component
securities, are not identical to the units sold in this offering.
Risk Factors
Risks Relating to our Sponsor, Management and Director Team
The ownership interest of our sponsor may change, and our sponsor may divest its ownership
interest in us before identifying . . ., page 68
8.Please revise your risk factor disclosure to state the risk, if applicable, that any
replacement sponsor could have difficulty finding a target.
February 6, 2025
Page 3
Risks Associated with Acquiring and Operating a Business with its Primary Operation in
China
Other PRC governmental authorities may take the view now or in the future that an approval
from them is required for an overseas . . ., page 87
9.Please revise your risk factor disclosure to specifically address the impact that PRC
law or regulation may have on the cash flows associated with the business
combination, including shareholder redemption rights.
General
10.Please disclose the material terms of any agreement regarding transfer restrictions on
your securities in a tabular format to the extent practicable, as required by Item
1603(a)(9) of Regulation S-K.
Please contact Ameen Hamady at 202-551-3891 or Kristina Marrone at 202-551-3429
if you have questions regarding comments on the financial statements and related
matters. Please contact Isabel Rivera at 202-551-3518 or Benjamin Holt at 202-551-6614
with any other questions.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction
cc:Giovanni Caruso